UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Diabetes care, 2020-01, Vol.43 (1), p.250-260

2020

Volltextzugriff (PDF)

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes care, 2016-07, Vol.39 (7), p.1186-1201

2016

Volltextzugriff (PDF)

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Diabetologia, 2020-02, Vol.63 (2), p.229-241

2020

Volltextzugriff (PDF)

To help aging populations, classify organismal senescence

Science (American Association for the Advancement of Science), 2019-11, Vol.366 (6465), p.576-578

2019

Volltextzugriff (PDF)

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Diabetologia, 2020-02, Vol.63 (2), p.229-241

2020

Volltextzugriff (PDF)

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development

Current diabetes reviews, 2017-01, Vol.13 (3), p.300-314

2017

Volltextzugriff (PDF)

Metformin-associated lactic acidosis: Current perspectives on causes and risk

Metabolism, clinical and experimental, 2016-02, Vol.65 (2), p.20-29

2016

Volltextzugriff (PDF)

Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapies

Diabetes/metabolism research and reviews, 2017-07, Vol.33 (5), p.n/a

2017

Volltextzugriff (PDF)

The inherent challenges of classifying senescence-Response

Science (American Association for the Advancement of Science), 2020-05, Vol.368 (6491), p.595-596

2020

Volltextzugriff (PDF)

Corrigendum to “Metformin-associated lactic acidosis: Current perspectives on causes and risk” [Metabolism 65 (2016) 20–29]

Metabolism, clinical and experimental, 2016-09, Vol.65 (9), p.1432-1433

2016

Volltextzugriff (PDF)

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Diabetes care, 2017-12, Vol.40 (12), p.1614-1621

2017

Volltextzugriff (PDF)

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Diabetes care, 2022-12, Vol.45 (12), p.3058-3074

2022

Volltextzugriff (PDF)

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Diabetologia, 2023-01, Vol.66 (1), p.3-22

2023

Volltextzugriff (PDF)

Improving the clinical value and utility of CGM systems: issues and recommendations: A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Diabetologia, 2017-12, Vol.60 (12), p.2319-2328

2017

Volltextzugriff (PDF)

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of diabetes science and technology, 2023-09, Vol.17 (5), p.1226-1242

2023

Volltextzugriff (PDF)

Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Diabetes care, 2015-04, Vol.38 (4), p.716-722

2015

Volltextzugriff (PDF)

854-P: ENT-03, a Centrally Acting Endogenous Spermine Bile Acid with PTP1B Inhibitory Activity, Has Potent Effects on Metabolism and Weight in a Mouse Model of Diet-Induced Obesity (DIO)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

105-LB: Evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Diabetologia, 2015-05, Vol.58 (5), p.862-870

2015

Volltextzugriff (PDF)

Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia

Journal of diabetes science and technology, 2024-03, p.19322968241240436-19322968241240436

2024

Volltextzugriff (PDF)

Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes

Journal of diabetes science and technology, 2024-05, Vol.18 (3), p.733-740

2024

Volltextzugriff (PDF)

Challenges in developing endpoints for type 1 diabetes intervention studies

Diabetes/metabolism research and reviews, 2009-11, Vol.25 (8), p.694-704

2009

Volltextzugriff (PDF)

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001

Diabetes, 2004-01, Vol.53 (1), p.250-264

2004

Volltextzugriff (PDF)

The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors

Journal of diabetes science and technology, 2024-11, Vol.18 (6), p.1346-1361

2024

Volltextzugriff (PDF)

1 – 25 von 178

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(178)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(80)
Humans
(73)
Female
(25)
Diabetes
(24)
Male
(24)
Endocrinology & Metabolism
(22)
Physical Sciences
(18)
Biological And Medical Sciences
(17)
Adult
(16)
Animals
(14)
Insulin
(13)
Medical Sciences
(13)
Technology
(13)
Physics
(12)
Child
(11)
General & Internal Medicine
(11)
Middle Aged
(11)
Science & Technology - Other Topics
(11)
Adolescent
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

To help aging populations, classify organismal senescence

Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Addressing Unmet Medical Needs in Type 1 Diabetes: A Review of Drugs Under Development

Metformin-associated lactic acidosis: Current perspectives on causes and risk

Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapies

The inherent challenges of classifying senescence-Response

Corrigendum to “Metformin-associated lactic acidosis: Current perspectives on causes and risk” [Metabolism 65 (2016) 20–29]

Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association

Improving the clinical value and utility of CGM systems: issues and recommendations: A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

854-P: ENT-03, a Centrally Acting Endogenous Spermine Bile Acid with PTP1B Inhibitory Activity, Has Potent Effects on Metabolism and Weight in a Mouse Model of Diet-Induced Obesity (DIO)

105-LB: Evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients

Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group

Advanced Glycation Endproducts: A Marker of Long-term Exposure to Glycemia

Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes

Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

Challenges in developing endpoints for type 1 diabetes intervention studies

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001

The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors

Suchergebnisse filtern